« Back to Record
Muntau, A. C., Bal, M. O., Gramer, G., Pazdírková, R., Cleary, M. A. M., Lotz-Havla, A. S., Munafo, A., Mould, D. D., Moreau-Stucker, F., Rogoff, D., Burlina, A., Eyskens, F. J. M. F., Freisinger, P., De Laet, C., Leuzzi, V., Rutsch, F., Sivri, H. S., & Vijay, S. (2017). Efficacy, safety and population pharmacokinetics of sapropterin in PKU patients <4 years: results from the SPARK open-label, multicentre, randomized phase IIIb trial. Orphanet journal of rare diseases, 12(1), 47. doi:10.1186/s13023-017-0600-x
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/249796



